Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on April 24, 2025
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 24, 2025
STOUGHTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report first quarter 2025 financial results after the market closes on Thursday, May 8, 2025. Following the release of the …
Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8, 2025
GlobeNewswire
·
April 24, 2025
TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 first quarter earnings conference call on Thursday, May 8, 2025 at 8:30 a.m. ET. Cronos’ senior management team will …
Performance Unlocked: AdOmni and LiveRamp Bring New Targeting and Attribution to CTV, OLV, and DOOH
GlobeNewswire
·
April 24, 2025
LAS VEGAS and SAN FRANCISCO, April 24, 2025 (GLOBE NEWSWIRE) -- Marketers have long struggled to measure the business impact of CTV, OLV, and DOOH—keeping these high-reach channels siloed from performance strategies. Today, AdOmni, the AI-powered video- …
Microchip Unveils New High-Density Power Module for AI at the Edge Applications
GlobeNewswire
·
April 24, 2025
CHANDLER, Ariz., April 24, 2025 (GLOBE NEWSWIRE) -- AI at the edge is driving increased integration and power consumption, requiring advanced power management solutions for industrial automation and data center applications. Microchip Technology (Nasdaq: …
Global Uranium and Forum Energy Metals Announce the Completion of Drilling and Ground Geophysical Surveys on the Northwest Athabasca Project, Saskatchewan
GlobeNewswire
·
April 24, 2025
CALGARY, Alberta, April 24, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the "Company" or “Global”) and Forum Energy Metals Corp. (TSX.V: FMC; OTCQB: FDCFF) (“Forum”) are pleased to announce that it has completed its …
NevGold Discovers More Significant Oxide Gold-Antimony Results: 2.11 g/t AuEq Over 67.1 Meters (1.30 g/t Au And 0.18% Antimony), Including 4.29 g/t AuEq Over 30.5 Meters (2.79 g/t Au And 0.33% Antimony), and Also Including 7.12 g/t AuEq Over 16.8…
GlobeNewswire
·
April 24, 2025
Vancouver, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has discovered further significant oxide gold-antimony (“Antimony”, “Sb”) …
Krystal Biotech to Present at Upcoming Scientific Conferences
GlobeNewswire
·
April 24, 2025
PITTSBURGH, April 24, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the Company will be presenting on multiple programs in the lung, eye, and skin at upcoming scientific conferences being held in May and …
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
GlobeNewswire
·
April 24, 2025
CAMBRIDGE, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
Australian Oilseeds Issues Annual Shareholder Letter
GlobeNewswire
·
April 24, 2025
COOTAMUNDRA, Australia, April 24, 2025 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited, a manufacturer and seller of sustainable edible oils to customers globally, today issued a letter to shareholders from Gary Seaton, Chairman and Chief …
Reviva to Present Late-Breaking Poster on the RECOVER Long-term Open Label Extension Trial for Brilaroxazine in Schizophrenia at the 2025 ASCP Annual Meeting
GlobeNewswire
·
April 24, 2025
CUPERTINO, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of …
FEC Sponsors Meta Crypto Oasis 2025 in Dubai — A Premier Web3 Event Set to Redefine Digital Engagement
GlobeNewswire
·
April 24, 2025
Dubai, UAE, April 24, 2025 (GLOBE NEWSWIRE) -- Under the esteemed Dubai Token 2049 banner, Meta Crypto Oasis 2025 is set to launch as one of the year’s most influential Web3 events. Sponsored by FEC, this global gathering will spotlight how everyday …
X4 Pharmaceuticals Announces Reverse Stock Split
GlobeNewswire
·
April 24, 2025
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that its board of directors has determined to effect a one-for-thirty …
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
GlobeNewswire
·
April 24, 2025
MARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Enable Medicine, a real-world data company providing AI-ready patient, cellular and molecular data, today announced a …
Rezolve Ai Smashes Past $50 Billion in GMV in Explosive start to 2025, Over 50 Major Enterprises Now Live and Scaling
GlobeNewswire
·
April 24, 2025
Now embedded on over 41.9 million consumer devices with 16.5 million monthly active users Delivering 8 billion+ API calls and 27.9 million GeoZone triggers so far this year NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), the company …
Snyk Achieves FedRAMP Moderate Authorization
GlobeNewswire
·
April 24, 2025
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Snyk, a leader in developer security, today announced it has achieved FedRAMP Moderate Authorization, completing the FedRAMP process for Snyk for Government. This achievement underscores Snyk’s commitment to …
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
GlobeNewswire
·
April 24, 2025
MARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, today announced the availability of a new assay designed to advance antibody-drug conjugate (ADC) development in breast cancer. The …
VoIP-Pal Files Second Amended Complaints in Federal Court and Serves Defendants
GlobeNewswire
·
April 24, 2025
CEO Emil Malak discusses the litigation strategy and consumer impact in a newly published article featured in CEO CFO Magazine WACO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- VoIP-Pal.com Inc. (“VoIP-Pal,” “Company”) (OTCQB: VPLM), announced that it has …
Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data
GlobeNewswire
·
April 24, 2025
April 28th AUA data presentation to highlight study in patients with high-grade non-muscle invasive bladder cancer (HG-NMIBC) Virtual event to be held on April 28, 2025 at 4:30 PM ET CORAL GABLES, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Relmada …
Fourth Annual RetailTech Breakthrough Awards Program Honors World’s Most Innovative Retail Technology Companies
GlobeNewswire
·
April 24, 2025
LOS ANGELES, April 24, 2025 (GLOBE NEWSWIRE) -- RetailTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout retail technology companies, products and services around the globe, today announced the …
ORYZON Raises €30 Million in Capital Increase
GlobeNewswire
·
April 24, 2025
Issued 12,765,958 new shares Priced at €2.35 per share, representing a 15.44% discount on the 5-day VWAP Strong investor demand, with the offering significantly oversubscribed €15 million anchored by a leading US institutional investor Proceeds to fund …